News
Empowering the biopharma industry with field-leading foundation models.
Recent News
Press
|
April 2, 2024
CB Insights Names Genesis to AI 100: The most promising AI startups of 2024
CB Insights
Press
|
March 6, 2024
Fierce Medtech's Fierce 15 of 2023
Fierce Biotech
Press
|
March 6, 2024
Fierce Medtech Names Genesis Therapeutics a "Fierce 15" Company of 2023
Business Wire
Presentations & Publications
|
October 31, 2023
a16z's Bio Eats Health: Supercharging Discovery with Evan Feinberg
a16z
Press
|
August 24, 2023
Genesis Therapeutics raises $200 million for AI-aided drug discovery
C&EN
Press
|
August 22, 2023
Genesis Therapeutics scores $200 million for AI drug discovery
San Francisco Business Times
Press
|
August 21, 2023
Genesis Therapeutics raises $200M for AI drug discovery based on Stanford research
Endpoints News
Press
|
August 21, 2023
WSJ: Andreessen Co-Leads $200 Million Investment in Biotech Startup Genesis Therapeutics
WSJ
Join Us
Opportunities in AI and Physics Research
Our molecular AI research team is pioneering new frameworks for drug discovery, at the intersection of multi-dimensional ML models and physical simulation. See opportunities in software engineering, machine learning and computation chemistry.
Software Engineering
Machine Learning
Computational Chemistry
